Thyroid adverse effects of psychotropic drugs: A review

Clinical Neuropharmacology

Volumn 34, Issue 6, 2011, Pages 248-255

  Khalil, Rami Bou ^a,b,c   Richa, Sami ^a,b  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

^c Psychiatric Hospital of the Cross   (Lebanon)

Author keywords

antidepressant drugs; antipsychotic drugs; mood stabilizers; side effects; thyroid function

Indexed keywords

ALIMEMAZINE; AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; DIAZEPAM; FLUOXETINE; FLUPENTIXOL; FLUPHENAZINE; LITHIUM; METHADONE; METHYLPHENIDATE; NEUROLEPTIC AGENT; ORPHENADRINE; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; PROPRANOLOL; PSYCHOTROPIC AGENT; QUETIAPINE; REBOXETINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ATTENTION DEFICIT DISORDER; AUTOIMMUNE THYROIDITIS; BIPOLAR DISORDER; DEPRESSION; DRUG MEGADOSE; DRUG WITHDRAWAL; EPILEPSY; FREE THYROXINE INDEX; GOITER; HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPERTHYROXINEMIA; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MAJOR DEPRESSION; META ANALYSIS; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROIDITIS; THYROTOXICOSIS; THYROXINE BLOOD LEVEL;

ANIMALS; HUMANS; PSYCHOTROPIC DRUGS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES;

EID: 81955164230     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31823429a7     Document Type: Review

References (95)

1. Sabeen S, Chou C, Holroyd S. Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. Arch Gerontol Geriatr 2010;51(1):6-8. E-pub July 17, 2009.
2. Fagiolini A. Medical monitoring in patients with bipolar disorder: a review of data. J Clin Psychiatry 2008;69(6):e16.
3. Farmer A, Korszun A, Owen MJ, et al. Medical disorders in people with recurrent depression. Br J Psychiatry 2008;192(5):351-355. (Pubitemid 351692379)
4. Rasgon NL, Kenna HA, Wong ML, et al. Hypothalamic-pituitary-end organ function in women with bipolar depression. Psychoneuroendocrinology 2007;32(3):279-286. E-pub Feb 20, 2007. (Pubitemid 46400280)
5. Fountoulakis KN, Kantartzis S, Siamouli M, et al. Peripheral thyroid dysfunction in depression. World J Biol Psychiatry 2006;7(3):131-137. (Pubitemid 44137013)
6. Tichomirowa MA, Keck ME, Schneider HJ, et al. Endocrine disturbances in depression. J Endocrinol Invest 2005;28(1):89-99. (Pubitemid 43162814)
7. Kikuchi M, Komuro R, Oka H, et al. Relationship between anxiety and thyroid function in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005;29(1):77-81. (Pubitemid 40018208)
8. Kelly DL, Conley RR. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 2005;66(1):80-84.
9. Fountoulakis KN, Iacovides A, Grammaticos P, et al. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry 2004;4:6.
10. Bauer M, Whybrow PC. Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatry 2001;2(2):59-69.
11. Engum A, BjLro T, Mykletun A, et al. An association between depression, anxiety and thyroid functionVa clinical fact or an artefact? Acta Psychiatr Scand 2002;106(1):27-34. (Pubitemid 34828145)
12. Bunevicius R. Thyroid disorders in mental patients. Curr Opin Psychiatry 2009;22(4):391-395.
13. Bunevicius R, Prange AJ Jr. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry 2010;23(4):363-368.
14. Sauvage MF, Marquet P, Rousseau A, et al. Relationship between psychotropic drugs and thyroid function: a review. Toxicol Appl Pharmacol 1998;149(2):127-135. (Pubitemid 28202357)
15. Verrotti A, Scardapane A, Manco R, et al. Antiepileptic drugs and thyroid function. J Pediatr Endocrinol Metab 2008;21(5):401-408. (Pubitemid 351894987)
16. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23(6):723-733.
17. Blumberg AG, Klein DF. Chlorpromazine-procyclidine and imipramine: effects on thyroid function in psychiatric patients. Clin Pharmacol Ther 1969;10(3):350-354.
18. Oltman JE, Friedman S. Protein-bound iodine in patients receiving perphenazine. JAMA 1963;185:726-727.
19. Mayer SW, Kelly FH, Morton ME. The direct antithyroid action of reserpine, chlorpromazine and other drugs. J Pharmacol Exp Ther 1956;117(2):197-201.
20. Foldes J, Nagy J, Kertai P, et al. Effect of chlorpromazine on thyroid activity. Acta Med Acad Sci Hung 1959;14:371-378.
21. Lamberg BA, Linnoila M, Fogelholm R, et al. The effect of psychotropic drugs on the TSH response to thyroliberin (TRH). Neuroendocrinology 1977;24(2):90-97. (Pubitemid 8262416)
22. Tuomisto J, Männistö P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985;37(3):249-332. (Pubitemid 16107648)
23. Poyraz BC, Aksoy C, Balciolu I. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. Eur Neuropsychopharmacol 2008;18(9):667-672. E-pub June 6, 2008.
24. Wetzel H, Wiesner J, Hiemke C, et al. Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers. J Psychiatr Res 1994;28(5):461-473.
25. Gründer G, Wetzel H, Schlösser R, et al. Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 1999;45(1):89-97. (Pubitemid 29049209)
26. Paunovi VR, Timotijevi I, Marinkovi D. Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol. Int Clin Psychopharmacol 1991;6(3):133-139.
27. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother 2000;34(4):483-486. (Pubitemid 30193782)
28. Church CO, Callen EC. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother 2009;43(12):2113-2116. E-pub Nov 24, 2009.
29. Kelly DL, Conley RR. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 2005;66(1):80-84.
30. Takorabet L, Ropars A, Stasiuk L, et al. Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity? Clin Exp Immunol 1998;111(2):415-421. (Pubitemid 28088327)
31. Shelton RC, Winn S, Ekhatore N, et al. The effects of antidepressants on the thyroid axis in depression. Biol Psychiatry 1993;33(2):120-126. (Pubitemid 23069196)
32. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatry 1989;25(6):703-709. (Pubitemid 19101987)
33. Joffe RT, Singer W. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry 1990;23(2):67-69. (Pubitemid 20159954)
34. Nordgren L, von Schéele C. Nortriptyline and pituitary-thyroid function in affective disorder. Pharmacopsychiatria 1981;14(2):61-65. (Pubitemid 11074422)
35. Linnoila M, Gold P, Potter WZ, et al. Tricyclic antidepressants do not alter thyroid hormone levels in patients suffering from a major affective disorder. Psychiatry Res 1981;4(3):357-360. (Pubitemid 11081697)
36. Rousseau A, Comby F, Buxeraud J, et al. Spectroscopic analysis of charge transfer complex formation and peroxidase inhibition with tricyclic antidepressant drugs: potential anti-thyroid action. Biol Pharm Bull 1996;19(5):726-728. (Pubitemid 26187884)
37. Fatimi J, Lagorce JF, Chabernaud ML, et al. Synthesis and antithyroid activity of 1,4,5-trialkyl 2-thioimidazole derivatives. Farmaco 1994;49(4):253-257. (Pubitemid 24165646)
38. Joffe RT, Sokolov ST. Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994;8(1-2):45-63. (Pubitemid 24024905)
39. Baumgartner A. Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int J Neuropsychopharmacol 2000;3(2):149-165. (Pubitemid 30429359)
40. Gitlin M, Altshuler LL, Frye MA, et al. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J Psychiatry Neurosci 2004;29(5):383-386. (Pubitemid 39572376)
41. König F, Hauger B, von Hippel C, et al. Effect of paroxetine on thyroid hormone levels in severely depressed patients. Neuropsychobiology 2000;42(3):135-138.
42. de Carvalho GA, Bahls SC, Boeving A, et al. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function. Thyroid 2009;19(7):691-697.
43. Gambi F, De Berardis D, Sepede G, et al. Effect of mirtazapine on thyroid hormones in adult patients with major depression. Int J Immunopathol Pharmacol 2005;18(4):737-744.
44. Eker SS, Akkaya C, Sarandol A, et al. Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(4):955-961. (Pubitemid 351609229)
45. Ferko N, Levine MA. Evaluation of the association between St. Johnaposs wort and elevated thyroid-stimulating hormone. Pharmacotherapy 2001;21(12):1574-1578. (Pubitemid 33117259)
46. Pfeifer WD, Davis LC, van der Velde CD. Lithium accumulation in some endocrine tissues. Acta Biol Med Ger 1976;35(11):1519-1523. (Pubitemid 8133199)
47. Spaulding SW, Burrow GN, Bermudez F, et al. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metab 1972;35(6):905-911.
48. Terao T, Oga T, Nozaki S, et al. Possible inhibitory effect of lithium on peripheral conversion of thyroxine to triiodothyronine: a prospective study. Int Clin Psychopharmacol 1995;10(2):103-105.
49. Lazarus JH, John R, Bennie EH, et al. Lithium therapy and thyroid function: a long-term study. Psychol Med 1981;11(1):85-92. (Pubitemid 11148564)
50. Perrild H, Hegedüs L, Arnung K. Sex related goitrogenic effect of lithium carbonate in healthy young subjects. Acta Endocrinol (Copenh) 1984;106(2):203-208. (Pubitemid 14107038)
51. Schou M, Amdisen A, Eskjaer Jensen S, et al. Occurrence of goiter during lithium treatment. Br Med J 1968;3(5620):710-713.
52. Perrild H, Hegedüs L, Baastrup PC, et al. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatry 1990;147(11):1518-1521. (Pubitemid 20365444)
53. Bauer M, Blumentritt H, Finke R, et al. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders. J Affect Disord 2007;104(1-3):45-51. E-pub March 7, 2007. (Pubitemid 350052301)
54. Waldman SA, Park D. Myxedema coma associated with lithium therapy. Am J Med 1989;87(3):355-356.
55. Ahmadi-Abhari SA, Ghaeli P, Fahimi F, et al. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry 2003;3:4. E-pub May 10, 2003.
56. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 1995;91(1):48-51.
57. Kirov G. Thyroid disorders in lithium-treated patients. J Affect Disord 1998;50(1):33-40. (Pubitemid 28338302)
58. Deodhar SD, Singh B, Pathak CM, et al. Thyroid functions in lithium-treated psychiatric patients: a cross-sectional study. Biol Trace Elem Res 1999;67(2):151-163. (Pubitemid 29159819)
59. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999;175:336-339. (Pubitemid 29470863)
60. Kirov G, Tredget J, John R, et al. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord 2005;87(2-3):313-317. (Pubitemid 41039954)
61. Bocchetta A, Cocco F, Velluzzi F, et al. Fifteen-year follow-up of thyroid function in lithium patients. J Endocrinol Invest 2007;30(5):363-366. (Pubitemid 47098230)
62. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992;86(1):38-41.
63. Bocchetta A, Mossa P, Velluzzi F, et al. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 2001;21(6):594-598. (Pubitemid 33116659)
64. Baethge C, Blumentritt H, Berghöfer A, et al. Long-term lithium treatment and thyroid antibodies: a controlled study. J Psychiatry Neurosci 2005;30(6):423-427. (Pubitemid 41812489)
65. Chow CC, Cockram CS. Thyroid disorders induced by lithium and amiodarone: an overview. Adverse Drug React Acute Poisoning Rev 1990;9(4):207-222.
66. Barclay ML, Brownlie BE, Turner JG, et al. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 1994;40(6):759-764. (Pubitemid 24216625)
67. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001;55(4):501-508. (Pubitemid 32955488)
68. Liewendahl K, Majuri H, Helenius T. Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs. Clin Endocrinol (Oxf) 1978;8(3):185-191. (Pubitemid 8287886)
69. Isojärvi JI, Pakarinen AJ, Myllylä VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33(1):142-148.
70. Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991;12(2):135-150.
71. Isojärvi JI, Airaksinen KE, Mustonen JN, et al. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia 1995;36(8):810-816.
72. Simko J, Horacek J. Carbamazepine and risk of hypo-thyroidism: a prospective study. Acta Neurol Scand 2007;116(5):317-321. (Pubitemid 47537412)
73. Lossius M I, TaubLll E, Mowinckel P, et al. Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study. Epilepsy & Behavior 2009;16(1):64-68.
74. Isojärvi JI, Turkka J, Pakarinen AJ, et al. Thyroid function in men taking carbamazepine, oxcarbazepine or valproate for epilepsy. Epilepsia 2001;42(7):930-934. (Pubitemid 32783103)
75. Ericsson UB, Bjerre I, Forsgren M, et al. Thyro-globulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine and valproic acid. Epilepsia 1985;26(6):594-596. (Pubitemid 16146132)
76. Bentsen KD, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurol Scand 1983;67(4):235-241. (Pubitemid 13115263)
77. Hamed SA, Hamed EA, Kandil MR, et al. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 2005;66(1-3):173-183. (Pubitemid 41393953)
78. Harvey RF. Drugs and thyroid-function tests. Br Med J 1967;2(5543):52.
79. Walton JG, Thompson JW. Pharmacology for the dental practitioner. 8. Drug interactions, drug-induced diseases and drugs in pregnancy. Br Dent J 1969;127(8):379-386.
80. Mazzaferri EL, Skillman TG. Diazepam (Valium) and thyroid function: a double-blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci 1969;257(6):388-394.
81. Greenberg AH, Czernichow P, Blizzard RM. Diazepam (Valium(R)) in thyrotoxicosis. Negative results. Johns Hopkins Med J 1970;126(3):134-138.
82. Clark F, Hall R, Ormston BJ. Diazepam and tests of thyroid function. Br Med J 1971;1(5749):585-586.
83. Webster JB, Coupal JJ, Cushman P Jr. Increased serum thyroxine levels in euthyroid narcotic addicts. J Clin Endocrinol Metab 1973;37(6):928-934.
84. Borst GC, Eil C, Burman KD. Euthyroid hyperthyroxinemia. Ann Intern Med 1983;98(3):366-378. (Pubitemid 13158510)
85. Stockigt JR, Barlow JW. The diagnostic challenge of euthyroid hyperthyroxinemia. Aust N Z J Med 1985;15(2):277-284.
86. English TN, Ruxton D, Eastman CJ. Abnormalities in thyroid function associated with chronic therapy with methadone. Clin Chem 1988;34(11):2202-2204. (Pubitemid 19001234)
87. Ilias I, Kakoulas I, Christakopoulou I, et al. Thyroid function of former opioid addicts on naltrexone treatment. Acta Medica (Hradec Kralove) 2001;44(1):33-35.
88. Cooper DS, Daniels GH, Ladenson PW, et al. Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 1982;73(6):867-871. (Pubitemid 13211832)
89. Mooradian A, Morley JE, Simon G, et al. Propranolol-induced hyperthyroxinemia. Arch Intern Med 1983;143(11):2193-2195. (Pubitemid 14225197)
90. Ljubici N, Ljubici-Mari S, Bili A, et al. The effect of propranolol on thyroid function in patients with liver cirrhosis. Z Gastroenterol 1991;29(6):286-288.
91. Bernardi M, De Palma R, Trevisani F, et al. Low T3 syndromeaposapos in cirrhosis: effect of beta-blockade. Am J Gastroenterol 1989;84(7):727-731. (Pubitemid 19184372)
92. Moberg E, Hägg E, Asplund K, et al. Misleading T3-test values in psychiatric patients treated with orphenadrine. Acta Med Scand 1987;222(4):375-379. (Pubitemid 18049120)
93. Greeley GH Jr, Jahnke G, Nicholson GF, et al. Decreased serum 3,5,3¶-triiodothyronine and thyroxine levels accompanying acute and chronic ritalin treatment of developing rats. Endocrinology 1980;106(3):898-904. (Pubitemid 10135126)
94. Johnson M, Cederlund M, Rastam M, et al. Open-label trial of atomoxetine hydrochloride in adults with ADHD. J Atten Disord 2010;13(5):539-545. E-pub 2009 May 20.
95. Kramer CK, Tourinho TF, de Castro WP, et al. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Arch Med Res 2005;36:54-58. (Pubitemid 40386349)